Skip to content
ClinCalc Pro
Menu
Long-acting synthetic opioid

Methadone hydrochloride

Brand names: Physeptone

Methadone is a long-acting synthetic opioid agonist used in opioid substitution therapy for opioid dependence and also as an analgesic.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is a full agonist at the mu-opioid receptor with a long half-life, providing sustained suppression of withdrawal and craving, and additionally has NMDA-receptor antagonist activity.

Prescribing in practice

  • Methadone carries a high risk of fatal respiratory depression, particularly during initiation, dose titration and in opioid-naive individuals, and overdose risk is increased by concomitant alcohol, benzodiazepines or other CNS depressants.
  • It prolongs the QT interval and can cause torsade de pointes, so an ECG and review of cardiac risk factors and interacting medicines is advised.
  • Supervised consumption is commonly required at the start of treatment because of accumulation risk from its long half-life.

Monitoring

Monitor for sedation and respiratory depression during titration, assess QT interval where cardiac risk factors exist, and review treatment response regularly.

Counselling the patient

  • Do not drink alcohol or take other sedating medicines with methadone, as the combination can be fatal.
  • Keep this medicine locked away and out of reach of children, as even one dose can be fatal to a child.
  • Do not take extra doses if you feel a dose is not holding you; contact your service instead.

Evidence & guidelines

Methadone maintenance is an established evidence-based treatment for opioid dependence supported by NICE guidance, and the MHRA has highlighted the risks of QT prolongation and respiratory depression.

Reference: NICE CG52; PHE/UK clinical guidelines on drug misuse; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.